Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

J&J Opens JLABS @ Shanghai, a Life Science Incubator with 31 Resident Startups

publication date: Jun 27, 2019

Johnson & Johnson announced the opening its life science incubator, JLABS @ Shanghai, the world's largest JLABS and the first in Asia Pacific. The facility has room for over 50 pharmaceutical, medical device, consumer and health tech companies. It has already signed up with 31 resident companies, including the three awardees of the Lung Cancer Innovation QuickFire Challenge. The 4,400-square-meter facility, located in Shanghai's Zhangjiang Hi-Tech Park, is a collaboration with Shanghai Pharma Engine. JLABS was developed by J&J Innovation, a Division of Johnson & Johnson (China) Investment. More details....

Stock Symbol: (NYSE: JNJ)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.